Aptorum Group Limited Class A Stock price
Is Aptorum Group Limited Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Aptorum Group Limited Class A Stock Analysis
Analyst Opinions
6 Analysts have issued a Aptorum Group Limited Class A forecast:
Analyst Opinions
6 Analysts have issued a Aptorum Group Limited Class A forecast:
Don't miss a Thing! We will send you all news about Aptorum Group Limited Class A directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Aptorum Group Limited Class A Stock News
Company Profile
Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.
| Head office | Cayman Islands |
| CEO | Mr. Huen |
| Employees | 1 |
| Founded | 2010 |
| Website | www.aptorumgroup.com |


